Kura Oncology, Inc. - stock earnings
KURA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -42.8 million USD | 1.3 million USD |
| 2023Q3 | -38.6 million USD | ? USD |
| 2023Q2 | -37.2 million USD | ? USD |
| 2023Q1 | -31.0 million USD | ? USD |
| 2022Q4 | -33.3 million USD | ? USD |
| 2022Q3 | -36.6 million USD | ? USD |
| 2022Q2 | -35.3 million USD | ? USD |
| 2022Q1 | -32.8 million USD | ? USD |
| 2021Q4 | -32.7 million USD | ? USD |
| 2021Q3 | -33.4 million USD | ? USD |
| 2021Q2 | -33.7 million USD | ? USD |
| 2021Q1 | -30.7 million USD | ? USD |
| 2020Q4 | -26.2 million USD | ? USD |
| 2020Q3 | -23.8 million USD | ? USD |
| 2020Q2 | -20.5 million USD | ? USD |
| 2020Q1 | -19.2 million USD | ? USD |
| 2019Q4 | -17.9 million USD | ? USD |
| 2019Q3 | -16.4 million USD | ? USD |
| 2019Q2 | -14.9 million USD | ? USD |
| 2019Q1 | -13.9 million USD | ? USD |
| 2018Q4 | -16.1 million USD | 2.4 million USD |
| 2018Q3 | -15.0 million USD | ? USD |
| 2018Q2 | -14.7 million USD | ? USD |
| 2018Q1 | -14.6 million USD | ? USD |
| 2017Q4 | -10.7 million USD | ? USD |
| 2017Q3 | -9.3 million USD | ? USD |
| 2017Q2 | -7.8 million USD | ? USD |
| 2017Q1 | -7.5 million USD | ? USD |
| 2016Q4 | -7.3 million USD | ? USD |
| 2016Q3 | -6.9 million USD | ? USD |
| 2016Q2 | -6.7 million USD | ? USD |
| 2016Q1 | -6.6 million USD | ? USD |
| 2015Q4 | -6.5 million USD | ? USD |
| 2015Q3 | -6.1 million USD | ? USD |
| 2015Q2 | -5.6 million USD | ? USD |
| 2015Q1 | -4.5 million USD | ? USD |
| 2014Q4 | -9530 USD | ? USD |
| 2014Q3 | -6428 USD | ? USD |
| 2014Q2 | -6887 USD | ? USD |
| 2014Q1 | -5766 USD | ? USD |
| 2013Q4 | -8454 USD | ? USD |
| 2013Q3 | -6139 USD | ? USD |
| 2013Q2 | -6749 USD | ? USD |
| 2013Q1 | -5973 USD | ? USD |
| 2012Q4 | -9387 USD | ? USD |
| 2012Q3 | -6013 USD | ? USD |
| 2012Q2 | -6268 USD | ? USD |
| 2012Q1 | -5372 USD | ? USD |
| 2011Q4 | -4239 USD | ? USD |
| 2011Q3 | -6267 USD | ? USD |
| 2011Q2 | -11889 USD | ? USD |
| 2011Q1 | -5154 USD | ? USD |
| 2010Q3 | -4767 USD | ? USD |
| 2010Q2 | -5576 USD | ? USD |
| 2010Q1 | -4306 USD | ? USD |
| 2009Q2 | -3627 USD | ? USD |
KURA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -152.6 million USD | ? USD |
| 2022 | -136.1 million USD | ? USD |
| 2021 | -129.9 million USD | ? USD |
| 2020 | -89.4 million USD | ? USD |
| 2019 | -63.1 million USD | ? USD |
| 2018 | -60.4 million USD | ? USD |
| 2017 | -35.4 million USD | ? USD |
| 2016 | -27.6 million USD | ? USD |
| 2015 | -22.6 million USD | ? USD |
| 2014 | -3.7 million USD | ? USD |
| 2013 | -27315 USD | ? USD |
| 2012 | -27040 USD | ? USD |
| 2011 | -22395 USD | ? USD |
| 2010 | -22395 USD | ? USD |
| 2009 | -19996 USD | ? USD |
| 2008 | -33623 USD | ? USD |
KURA
Price: $20.28
52 week price:
Earnings Per Share: -2.08 USD
P/E Ratio: -10.46
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 495600
Ebitda: -9.1 millionMarket Capitalization: 1.6 billion